ADC Therapeutics (ADCT) Gross Profit (QoQ) (2021 - 2025)

ADC Therapeutics (ADCT) Gross Profit (QoQ) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 472.40 Bn 467.61 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.23 Bn 114.98 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.05 Bn 61.29 Bn 3.31 Bn
7 Belite Bio 62.46 Bn 62.46 Bn -
8 Argenx Se 55.94 Bn 50.76 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn
10 ADC Therapeutics 180.35 Mn -50.66 Mn 17.38 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 -15.43%
Jun 30, 2025 -14.16%
Sep 30, 2024 8.77%
Jun 30, 2024 4.18%
Sep 30, 2023 -21.36%
Jun 30, 2023 -2.38%
Sep 30, 2022 399.34%
Jun 30, 2022 -67.31%
Sep 30, 2021 247.49%